BioVascular (San Diego, CA) a development stage biotechnology company focused on novel cardiovascular therapeutics closed a $10.8M Series C financing. Participants include BB Biotech Ventures and Domain Associates.

NGM Biopharmaceuticals (Hillsborough, CA) an early-stage drug development company focused on metabolic diseases closed a $25.5M Series A financing. Participants include Column Group, Prospect Venture Partners and Rho Ventures.

Point Biomedical (San Carlos, CA) a myocardial perfusion imaging platform has closed a $50M Series A recapitalization financing. Participants include Vedanta Capital, Amberbrook, Fininvest, INVESCO Private Capital, New Leaf Venture Partners, Saratoga Ventures, William Blair Capital Partners, De Novo Ventures, Institutional Venture Partners, Saints Capital, Sprout Group and CHL Medical Partners.

Sonexa Therapeutics (San Diego, CA) a development stage biopharmaceutical company focused on the treatment of Alzheimer’s disease closed a $30M Series A financing. Participants include Domain Associates, Scale Venture Partners, Alta Partners, AgeChem Venture Fund and MC Life Science Ventures.

Oraya (Menlo Park, CA) a ophthalmology medical device company in stealth mode has closed a $18M Series B financing. Participants include Synergy Life Science Partners and Essex Woodlands Health Ventures.

ViOptix (Freemont, CA) developer of optical diffusion imaging and spectroscopy technology to enable non-invasive measurement of local tissue oxygen saturation closed a $12.2M Series D. Participants include Channel Medical Partners, Lincoln Funds International, Canadian Medical Discoveries Fund and Morningside Technology Ventures.

CyberHeart (Menlo Park, CA) a medical device company developing the first totally non-invasive system to treat cardiac arrhythmias closed a $9M Series A financing. Participants include Emergent Medical Ventures, and United Investments, Venture Select and Mitsubishi Corporation.

Aragon Surgical (Palo Alto, CA) developer of surgical instruments for electrosurgical and laparoscopic enabling tools closed a $25M Series B financing. Participants include Bay City Capital, Integral Capital Partners, Delphi Ventures and Onset Ventures.

Benvenue Medical (Mountain View, CA) developer of minimally invasive devices for spine surgery closed a $15M Series B financing. Participants include Three Arch Partners, Versant Ventures and De Novo Ventures.

Autonomic Technologies (Menlo Park, CA) makers of neuromdoulation stimulation devices closed on the first $3M traunche of a $5M Series A financing. Participants in the round include Kleiner Perkins Caufield & Byers and the Cleveland Clinic.